$TransMedics Group, Inc.(TMDX)$ IS EXTREMELY UNDERVALUED đľ
PRICE TARGET: $206
POTENTIAL UPSIDE: +148% â
ASSUMPTIONS:
LTM Revenue: $0.6685B
5Y Revenue CAGR: 21%
2031 Profit Margin: 24%
2031 PE Ratio: 35
Shares outstanding: 0.0407B
Shares dilution: 2%/year
VALUATION:
Q2 2031
$TMDX SHARE PRICE =0.6685 * (1.21)^5 * 0.24 * 35 /[0.0407 * (1.02)^5] = 324$
You can now choose the discount rate that you prefer, for Transmedics I want to use 12%
ACTUAL PRICE: $83
FAIR VALUE: $184
PRICE TARGET (1Y): $206
POTENTIAL UPSIDE: +148%
EXPECTED RETURNS: 31.3%/year
DIVIDEND YIELD: -
- - - - - - - - - - - - - - -
đđŠđŞđ´ đąđ°đ´đľ đŞđ´ đ§đ°đł đŞđŻđ§đ°đłđŽđ˘đľđŞđ°đŻđ˘đ đ˘đŻđĽ đŚđĽđśđ¤đ˘đľđŞđ°đŻđ˘đ đąđśđłđąđ°đ´đŚđ´ đ°đŻđđş.
đ'đŽ đŻđ°đľ đ˘ đ§đŞđŻđ˘đŻđ¤đŞđ˘đ đ˘đĽđˇđŞđ´đ°đł and all the đŞđŻđ§đ°đłđŽđ˘đľđŞđ°đŻ đ¤đ°đŻđľđ˘đŞđŻđŚđĽ đŞđŻ đľđŠđŞđ´ đąđ°đ´đľ đŞđ´ đŻđ°đľ đ§đŞđŻđ˘đŻđ¤đŞđ˘đ đ˘đĽđˇđŞđ¤đŚ.
- - - - - - - - - - - - - - -
Do you own $TransMedics Group, Inc.(TMDX)$ shares?
Comments